enVVeno Medical Corporation (NVNO) Narxning foydaga nisbati

enVVeno Medical Corporation (NVNO) korporativ emblemasi va logotipi

enVVeno Medical (NVNO) kompaniyasining individual P/E ko'rsatkichi uchun pul birliklarida ifodalangan bozor tendentsiyasi -0.30 hisoblanadi. enVVeno Medical sug'urta to'lovlari orqali ixtisoslashtirilgan markazlarga noyob vena patologiyasi terapiyasi mahsulotlarini yetkazib berish orqali daromad keltiradi. Shu bilan birga, biznes ishlab chiqarish chiqindilarini kamaytirish orqali bioetik va ekologik tamoyillarga amal qilmoqda, garchi hozirda bozorga kirishdan oldin qimmatbaho klinik sinovlar uchun kapital sarflayotgan bo'lsa-da.

enVVeno Corp (NVNO) Narx-foyda koeffitsiyenti: 04.07.2022 - 17.11.2026 davri uchun

enVVeno Medical Corp. (NVNO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning umumiy tahlili:enVVeno Medical Corporation - NVNO
envveno.com original mahsuloti

Bozor kapitalizatsiyasining sof foydaga nisbati joriy daromadning bir dollari qiymatini belgilaydi va foyda o'sish sur'atlariga bo'lgan bozor kutuvlarini aks ettiradi. enVVeno Medical (NVNO) kompaniyasining P/E baholash tahlili kompaniyaning aktivlar qiymatini uning noyob bioprotez patentlari bilan solishtirish imkonini beradi va yuqori R&D xarajatlari hamda FDA sertifikatsiyasi biznes uchun uzoq muddatli himoya to'sig'ini yaratishini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Group (TMDX)|ATEC (Alphatec) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion)|Narx-foyda koeffitsiyenti ENOV (Enovis)|IART (Integra LifeSciences Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Establishment Labs Inc ESTA|BBNX - Narx-foyda koeffitsiyenti|IRADIMED Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Embecta Corp.|TNDM: P/E multiplikatori|Narx-foyda multiplikatori AXGN|SIBN (SI-BONE Medical) - P/E multiplikatori|Orthofix International (OFIX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BVS|Narx-foyda koeffitsiyenti OrthoPediatrics KIDS|P/E multiplikatori TMCI (treace.com)|P/E multiplikatori Blade Air Mobility SRTA|CARL - Narxning foydaga nisbati|RXST: Narxning foydaga nisbati|CLPT (ClearPoint) - Narx-foyda koeffitsiyenti|Stereotaxis, Inc. - Kompaniya qiymatining sof foydaga nisbati|STIM (Neuronetics, Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Sight Sciences Inc. SGHT|Narxning foydaga nisbati orchestrabiomed.com (OBIO)|Anika (ANIK) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|InspireMD Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Jin Medical International Ltd ZJYL|Vivani Medical Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati MODD (Modular Med)|MYO (Myomo Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Envoy Medical, Inc. (COCH)|P/E multiplikatori VVOS|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)